Clinical Research Directory

Inclusion Criteria: * patients with localized prostate adenocarcinoma at low-intermediate risk (EAU Risk classification); * patients aged \>= 18 years; * patients with an indication to undergo robotic radical prostatectomy without lymphadenectomy according to the EAU guidelines; * patients who agree to undergo robotic radical prostatectomy without lymphadenectomy according to the EAU guidelines by signing a written informed consent; * patients eligible for robotic radical prostatectomy without lymphadenectomy and in the absence of contraindications to undergo the procedure; * patient's ability to understand and willingness to sign a written informed consent indicating that he has understood the purpose and methods of conducting the study and is interested in participating.; * patients able to follow the indications specified in the study protocol; * patients domiciled (even temporarily) \< 150 km away from the institution where the procedure will be performed; * patients domiciled (even temporarily) \< 60 minutes by car from a reference Emergency and Acceptance Department (DEA). Exclusion Criteria: * patients \> 75 years of age; * ASA \> 2; * second simultaneous surgery; * prostate volume \> 80 cc estimated on preoperative imaging (transrectal ultrasound or magnetic resonance imaging); * patients receiving anticoagulants or oral antiplatelet drugs; * other concomitant tumors undergoing treatment; * previous pelvic radiotherapy; * previous surgery for benign prostatic hypertrophy; * patients lacking the digital literacy required to take advantage of telemedicine intervention; * patients who cannot benefit from at least one caregiver; * patients not suitable for a day-surgery approach based on the clinical evaluation of the operating surgeons and anesthetists.